Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.

Authors: Huang, Haoyang, Zhao, Yuping, Deng, Ying, Zhan, Zejiang, Huang, Yingying, Cao, Xun, Chen, Xi, Zhou, Jiayu, Liang, Chixiong, Zhang, Lulu, Luo, Zhuoying, Guo, Xiang, Lv, Xing

Source: International Journal of Cancer; Jan2025, Vol. 156 Issue 1, p174-185, 12p

Subject Terms: LIVER metastasis, NEOADJUVANT chemotherapy, NASOPHARYNX cancer, CONFIDENCE intervals, NOMOGRAPHY (Mathematics)

AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma.

Authors: Wibawa, Made Satria, Zhou, Jia-Yu, Wang, Ruoyu, Huang, Ying-Ying, Zhan, Zejiang, Chen, Xi, Lv, Xing, Young, Lawrence S., Rajpoot, Nasir

Source: Cancers; Dec2023, Vol. 15 Issue 24, p5789, 16p

Subject Terms: NASOPHARYNX cancer, DEEP learning, STATISTICS, CONFIDENCE intervals, CANCER relapse, RISK assessment, EPSTEIN-Barr virus, SURVIVAL analysis (Biometry), KAPLAN-Meier estimator, DESCRIPTIVE statistics, RESEARCH funding, TUMOR markers, PROGRESSION-free survival, LYMPHOCELE, ALGORITHMS, DISEASE risk factors

Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis.

Authors: Cai, Zhuochen, Chen, Dongni, Qiu, Wenze, Liang, Chixiong, Huang, Yingying, Zhou, Jiayu, Zhan, Zejiang, Xiang, Yanqun, Guo, Xiang, Lv, Xing

Source: Journal of Cancer Research & Clinical Oncology; Jun2023, Vol. 149 Issue 6, p2327-2344, 18p

Subject Terms: NASOPHARYNX cancer, PROPENSITY score matching, CHEMORADIOTHERAPY, RETROSPECTIVE studies, PROGRESSION-free survival, NASOPHARYNX tumors

An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling.

Authors: Zhou, Jiayu, Deng, Yishu, Huang, Yingying, Wang, Zhiyi, Zhan, Zejiang, Cao, Xun, Cai, Zhuochen, Deng, Ying, Zhang, Lulu, Huang, Haoyang, Li, Chaofeng, Lv, Xing

Source: Life (2075-1729); May2023, Vol. 13 Issue 5, p1167, 17p

Subject Terms: NASOPHARYNX cancer, PROGNOSTIC models, METABOLOMICS, DISEASE risk factors, RECEIVER operating characteristic curves, CATECHOL-O-methyltransferase

Improving mental health care among patients with cancer in China

Authors: Zhan, Zejiang, Yang, Yuan, Huang, Haoyang, Mai, Haiqiang, Guo, Xiang, Lv, Xing

Source: In The Lancet Psychiatry November 2023 10(11):831-832

Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors: Qiu, Wenze, Jiang, Jiali, Zhan, Zejiang, Huang, Laiji, Deng, Jin, Ye, Jiacai, Li, Guo, Liao, Kai, Zhang, Huanhuan, Ding, Yan, Yuan, Yawei, Zheng, Ronghui

Source: International Journal of Biological Markers; Mar2022, Vol. 37 Issue 1, p21-30, 10p

A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors: Qiang, Mengyun, Li, Chaofeng, Sun, Yuyao, Sun, Ying, Ke, Liangru, Xie, Chuanmiao, Zhang, Tao, Zou, Yujian, Qiu, Wenze, Gao, Mingyong, Li, Yingxue, Li, Xiang, Zhan, Zejiang, Liu, Kuiyuan, Chen, Xi, Liang, Chixiong, Chen, Qiuyan, Mai, Haiqiang, Xie, Guotong, Guo, Xiang

Source: JNCI: Journal of the National Cancer Institute; May2021, Vol. 113 Issue 5, p606-615, 10p

Subject Terms: SIGNAL convolution, DEEP learning, NASOPHARYNX cancer, NASOPHARYNX tumors, MAGNETIC resonance imaging, CONVOLUTIONAL neural networks, THERAPEUTIC use of antineoplastic agents, RESEARCH, RESEARCH methodology, PROGNOSIS, RETROSPECTIVE studies, EVALUATION research, COMPARATIVE studies

Nab-paclitaxel plus cisplatin versus docetaxel plus cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A multicenter parallel controlled phase III trial.

Authors: Lv, Xing, Zeng, Qi, Zhang, Weijun, Cheng, Hao, Xia, Weixiong, Yanqun, Xiang, Liang, Hu, Cao, Xun, Chen, Xi, Zhan, Zejiang, Deng, Ying, Zhou, Jiayu, Zhang, Lulu, Liang, Chixiong, Huang, Haoyang, Huang, Yingying, Cai, Zhuocheng, Guo, Xiang

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p6071-6071, 1p